相关实验视频
Updated: Feb 20, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.2K
对帕金森病的深度大脑刺激手术决策辅助的开发和可接受性
Michelle E Fullard1, Erika Shelton1, Ashley Dafoe2
1Department of Neurology, University of Colorado, Aurora, CO, USA.
Journal of Parkinson's disease
|February 18, 2026
概括
患有帕金森病 (PD) 的患者面临着关于深度大脑刺激 (DBS) 的复杂决策. 开发了一种新的决策辅助工具,并被认为是可以接受的,旨在改善DBS手术的共享决策.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 决策科学 决策科学 决策科学
背景情况:
- 对帕金森病 (PD) 的深度大脑刺激 (DBS) 为患者提供了复杂的选择.
- 决策支持工具可以加强共享决策并改善结果.
研究的目的:
- 为考虑DBS手术的PD患者开发决策辅助工具.
- 为了评估这个新开发的决策辅助的可接受性.
主要方法:
- 系统开发,包括需求评估和文献审查.
- 原型开发和对PD患者进行测试.
- 在临床环境中使用调查来评估可接受性.
主要成果:
- 136名PD参与者参与;需求评估显示了高决策冲突 (平均得分35.3).
- 该决策辅助工具最初由22名参与者进行了测试,然后由46名PD患者评估是否可接受.
- 87%的参与者对帮助决策的质量感到满意,认为其内容和呈现方式是可以接受的.
结论:
- 接受DBS评估的PD患者经历了显著的决策冲突.
- 成功创建了一个DBS决策辅助工具,以增强知识,管理期望,澄清价值观,并支持共享决策.
- 开发的决策辅助工具对于PD患者来说是可以接受的,无论他们的DBS状态如何.
更多相关视频
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.9K
12:04Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011
13.5K
相关概念视频
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K